Sarcoma biopsy market
Sarcoma Biopsy Market, by Product Type (Reusable Device and Disposable Devices), by End User (Hospitals, Ambulatory Surgical Centers, and Diagnostic Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
- May 2020
- CMI3819
- 151 Pages
- Excel & Pdf
- Clinical Diagnostic
Biopsy is a procedure of removing of a small amount of tissue for examination under a microscope. Imaging tests may suggest the diagnosis of sarcoma, but biopsy is performed to confirm the diagnosis and to find out the type of sarcoma. Several types of biopsies are used to diagnose sarcomas and most biopsies are needle biopsies, in which needle is used to access the suspicious tissue of sarcoma.
The global sarcoma biopsy market was valued at US$ 197.94 million in 2019 and is expected to exhibit a CAGR of 2.8% over the forecast period (2020-2027).
Fig1. Global Sarcoma Biopsy Market Share (%) Analysis, By Product Type, 2019
Increasing prevalence of osteosarcoma is expected to drive growth of the global sarcoma biopsy market.
Osteosarcoma is the most common type of cancer affecting bones, and it mostly occurs in children and young adults. On the basis of cells, osteosarcoma is classified as high-, intermediate- and low-grade. For instance, according to the American Cancer Society, IN January 2020, around 800 to 900 new cases of osteosarcoma are diagnosed in the U.S. each year, with around 50% occurs in children and teenagers.
There are different type of biopsy procedures used to diagnose osteosarcoma such as needle biopsy and surgical biopsy.
Global Sarcoma Biopsy Market– Regional Analysis
North America accounted for the largest market share in the global sarcoma biopsy market, owing to rising healthcare expenditure in the U.S. For instance, according to the Committee for a Responsible Federal Budget, in 2017, the U.S. spent around US $ 3.5 trillion, or 18% of the total GDP, on health expenditures, which is more than twice the average among developed countries.
Furthermore, Asia Pacific is also expected to witness significant growth in the global sarcoma biopsy market, owing to increasing healthcare facilities. For instance, according to the India Brand Equity Foundation, in 2015 around 156,926 sub centers, and 196,312 hospitals are present in India.
Fig.2 Global Sarcoma Biopsy Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2027
Global Sarcoma Biopsy Market- Competitive Landscape
Key players operating in the global sarcoma biopsy market include C. R. Bard, Inc., Becton, Dickinson and Company, Argon Medical Devices, InVivo Therapeutics Corporation, Cook Medical Incorporated, UROMED, and Sterylab
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- PEST Analysis
- Porter’s Five Forces model
- Market Dynamics
- Global Sarcoma Biopsy Market, By Product Type, 2016 – 2027, (US$ Million)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Reusable Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Disposable Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Introduction
- Global Sarcoma Biopsy Market, By End User, 2016 – 2027, (US$ Million)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Introduction
- Global Sarcoma Biopsy Market, By Region, 2016 – 2027, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, By Region, 2017 – 2027
- Regional Trends
- North America
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Africa
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Million)
- North Africa
- Central Africa
- South Africa
- Middle East
- Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Introduction
- Competitive Landscape
- Company Profiles
- C. R. Bard, Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Becton, Dickinson and Company
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Argon Medical Devices
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- InVivo Therapeutics Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Cook Medical Incorporated
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- UROMED
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Sterylab
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- C. R. Bard, Inc.
- Company Profiles
- Section
- References
- Research Methodology
- About Us and Sales Contact
*Browse 26 market data tables and 25 figures on "Global Sarcoma Biopsy Market” - Forecast to 2027”